Anixa Biosciences (ANIX)
Develops cancer vaccines and ovarian-cancer CAR-T therapy through institutional collaborations.
$2.75
vs last close−0.04 (−1.43%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 15.40% | 5.36M shares | |
|---|---|---|---|
| 66 holders · as of Jun 30, 2026 | |||
| Insiders | 28.39% | 9.87M shares | |
| 4 holders · as of Sep 14, 2026 | |||
| Other | 56.21% | 19.54M shares | |
| remainder | |||
34.76M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
66 holders · 5.36M shares · 11 new positions · 28 increased · 9 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.33M | 3.83% | +14.9K | Aug 13, 2026 |
| UBS Group AG | 585.4K | 1.68% | +33.8K | Aug 13, 2026 |
| Laird Norton Trust Company, LLC | 578.7K | 1.66% | +12.4K | Aug 14, 2026 |
| D.A. Davidson & Co. | 539.3K | 1.55% | 0 | Jul 24, 2026 |
| Geode Capital Management, LLC | 359.2K | 1.03% | −5.5K | Aug 12, 2026 |
| Marshall Wace, LLP | 328.3K | 0.94% | +155.2K | Aug 13, 2026 |
| BlackRock, Inc. | 199.8K | 0.57% | +29.7K | Aug 7, 2026 |
| Vanguard Fiduciary Trust Co | 192.4K | 0.55% | +1.3K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Amit Kumar | 16.30% | 6.17M | 13D | Jun 6, 2025 |
| Michael Catelani | 7.00% | 2.47M | 13D | Jan 6, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 10, 2026 | Amit Kumardirector, officer: Chief Executive Officer | Purchase · 2 lots | 8,000 | $2.76 | 665,000 |
| Sep 10, 2026 | Lewis H. jr Tittertondirector | Purchase | 10,000 | $2.73 | 996,967 |
| Jul 31, 2026 | Amit Kumardirector, officer: Chief Executive Officer | Purchase | 5,000 | $3.47 | 657,000 |
| Jul 27, 2026 | Amit Kumardirector, officer: Chief Executive Officer | Purchase · 2 lots | 8,188 | $3.41 | 652,000 |
| Jul 24, 2026 | Amit Kumardirector, officer: Chief Executive Officer | Purchase | 3,000 | $3.73 | 643,812 |
| Jul 20, 2026 | Amit Kumardirector, officer: Chief Executive Officer | Purchase | 5,000 | $3.46 | 640,812 |
| Jul 20, 2026 | Lewis H. jr Tittertondirector | Purchase | 12,000 | $3.47 | 986,967 |
| Jul 15, 2026 | Lewis H. jr Tittertondirector | Purchase | 2,797 | $3.28 | 974,967 |
| Jul 10, 2026 | Amit Kumardirector, officer: Chief Executive Officer | Purchase | 5,000 | $3.04 | 635,812 |
| Jun 16, 2026 | Lewis H. jr Tittertondirector | Purchase | 2,836 | $2.64 | 972,170 |
House and Senate disclosures
Not reported.